Not Signed In -
Benazepril |
Lotensin |
Image:Benazepril.png Benazepril Systematic (IUPAC) name 2-[4-(1-ethoxycarbonyl-3-phenyl-propyl) amino-5-oxo-6-azabicyclo[5.4.0] undeca-7,9,11- trien-6-yl]acetic acid Identifiers CAS number 86541-75-5 ATC code C09AA07 PubChem 5362124 DrugBank APRD00063 Chemical data Formula C24H28N2O5 Mol. weight 424.49 g/mol Pharmacokinetic data Bioavailability ? Protein binding 96.7% Metabolism ? Half life 10-11 hours Excretion ? Therapeutic consider ...
Wikipedia - [full article]
Benazepril Clinical Trials
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
Hypertension; Diabetic Nephropathy
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients with Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00136773 - Active, not recruiting
Albuminuria
- Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients with High Risk Hypertension
ClinicalTrials.gov Identifier: NCT00139555 - Active, not recruiting
Hypertension; Left Ventricular Hypertrophy
- Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
Heart Disease
- A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
ClinicalTrials.gov Identifier: NCT00171366 - Active, not recruiting
Hypertension
- A 6-Week Multi-Center, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension
ClinicalTrials.gov Identifier: NCT00136851 - Completed
Hypertension
- Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00367978 - Completed
Hypertension
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00367094 - Completed
Hypertension
- Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
ClinicalTrials.gov Identifier: NCT00185120 - Completed
Hypertension
- Benazepril for Advanced Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00270426 - Terminated
Chronic Kidney Failure
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
ClinicalTrials.gov Identifier: NCT00338091 - Terminated
Renal Insufficiency,Chronic; Disease Progression; Proteinuria; Dose-Response Relationship,Drug; ACE Inhibitor; Angiotensin II Type 1 Receptor Blockers
Resources
- Benazepril (Drug Digest)
- Lotensin (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
